This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.

Completed · Phase 2 · Has a placebo group

Conditions studied: Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

In brief

The purpose of this study is to assess the efficacy and safety of ZD6474 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

Key facts

Study ID
NCT00047840
Run by
Genzyme, a Sanofi Company
People needed
129
Starts
2002-10-01
Expected to finish
2006-09-01
Last updated by the study team
2016-08-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.